keyword
malaria
travel
medicin
fever
diagnost
antiparasit
therapi
chemoprophylaxi
malaria
common
worldwid
travel
malariaendem
destin
increas
travel
histori
obtain
children
present
fever
antigenbas
malaria
test
provid
rapid
malaria
diagnosi
although
blood
smear
still
necessari
treatment
malaria
depend
sever
ill
speci
malaria
parasit
epidemiolog
likelihood
drug
resist
centuri
ago
malaria
major
public
health
threat
unit
state
ongo
transmiss
southeastern
state
late
although
extens
effort
ultim
elimin
local
malaria
north
america
mosquitoborn
infect
remain
endem
throughout
much
world
inde
half
children
planet
live
malariaendem
countri
despit
continu
success
malaria
control
million
new
infect
year
nearli
half
million
death
mostli
infant
children
younger
year
old
importantli
increasingli
global
societi
malaria
import
infecti
diseas
remain
particular
concern
north
american
travel
nearli
american
malaria
case
acquir
abroad
articl
offer
brief
overview
plasmodium
parasit
respons
malaria
epidemiolog
infect
clinic
featur
associ
uncompl
sever
malaria
present
prevent
measur
travel
current
treatment
strategi
childhood
malaria
infect
malaria
caus
infect
intracellular
protozoan
parasit
genu
plasmodium
transmit
bite
femal
anophel
spp
mosquito
feed
infect
mosquito
leav
behind
sporozoit
infecti
motil
form
parasit
sporozoit
migrat
liver
asymptomat
invad
hepatocyt
amplifi
infect
releas
ten
thousand
daughter
parasit
releas
initi
asexu
erythrocyt
replic
stage
parasit
life
cycl
stage
parasit
respons
malaria
pathogenesi
two
speci
plasmodium
p
vivax
p
oval
uniqu
develop
dormant
parasit
form
call
hypnozoit
may
remain
liver
month
year
primari
infect
caus
relaps
recurr
symptomat
diseas
clinic
symptom
malaria
due
cycl
asexu
replic
within
red
blood
cell
fig
fever
hallmark
symptom
trigger
erythrocyt
ruptur
parasit
releas
everi
day
depend
plasmodium
speci
sever
lifethreaten
malaria
may
result
high
parasit
burden
caus
hemolysi
sever
anemia
endorgan
damag
due
vascular
adher
infect
erythrocyt
microocclus
persontoperson
transmiss
mediat
mosquito
sexual
form
parasit
gametocyt
infect
feed
mosquito
thu
complet
parasit
complex
life
cycl
epidemiolog
half
world
popul
live
area
malaria
transmiss
occur
diseas
continu
caus
major
public
health
burden
popul
area
africa
asia
central
south
america
fig
million
case
malaria
report
result
nearli
half
million
death
estim
time
higher
number
peopl
lost
arm
conflict
year
malariaassoci
death
caus
p
falciparum
speci
subsaharan
africa
kill
african
children
younger
age
year
daili
global
malaria
control
effort
focus
mosquito
vector
control
strategi
improv
access
effect
antimalari
therapi
tremend
gain
last
decad
incid
malaria
drop
death
decreas
global
howev
drug
resist
continu
hamper
control
effort
worldwid
widespread
resist
former
firstlin
agent
chloroquin
sulfadoxinepyrimethamin
remark
discoveri
artemisinin
nobel
laureat
youyou
tu
ultim
led
develop
rapidli
parasiticid
artemisininbas
combin
therapi
act
power
weapon
face
rise
resist
older
antimalari
unfortun
emerg
artemisininresist
p
falciparum
southeast
asia
year
act
implement
emphas
import
sustain
control
measur
ongo
need
antimalari
develop
though
malari
transmiss
remain
possibl
area
unit
state
anophelin
mosquito
found
nearli
annual
report
case
malaria
unit
state
infect
acquir
abroad
rare
unusu
mode
transmiss
also
report
includ
inadvert
airplan
transport
mosquito
endem
area
congenit
transmiss
transfusionassoci
malaria
contamin
needl
syring
uncompl
malaria
infect
typic
manifest
nonspecif
febril
ill
similar
present
influenza
common
viral
infect
travel
acut
malaria
often
present
within
day
month
follow
infect
mosquito
bite
malaria
suspect
febril
travel
malaria
symptom
highli
variabl
may
includ
chill
rigor
sweat
headach
lethargi
myalgia
cough
gastrointestin
symptom
may
promin
includ
avail
http
nausea
emesi
diarrhea
abdomin
pain
addit
fever
physic
find
may
reflect
endorgan
involv
includ
pallor
tachycardia
hepatosplenomegali
jaundic
increas
respiratori
rate
well
case
cerebr
malaria
alter
mental
statu
cours
diseas
may
indol
fulmin
delay
lack
treatment
beyond
hour
follow
onset
clinic
symptom
may
result
rapid
progress
lifethreaten
sever
malari
diseas
children
younger
year
age
tend
present
sooner
like
develop
sever
malaria
note
classic
cyclic
fever
pattern
describ
malaria
may
present
travel
young
children
parasit
life
cycl
may
synchron
time
treatment
sought
unsurprisingli
travel
like
present
sever
malaria
compar
semiimmun
resid
endem
area
addit
risk
factor
develop
sever
malaria
includ
recent
travel
p
falciparumendem
region
especi
subsaharan
africa
age
older
year
younger
year
pregnanc
exist
medic
condit
lack
malaria
prophylaxi
treatment
delay
sever
malaria
may
manifest
follow
syndrom
cerebr
malaria
caus
parasit
adher
cerebr
vasculatur
symptom
may
includ
alter
mental
statu
coma
seizur
evid
increas
intracrani
pressur
blackwat
fever
acut
renal
failur
hemoglobinuria
caus
intravascular
hemolysi
sever
anemia
defin
hemoglobin
less
gdl
caus
high
parasit
burden
hemolysi
infect
erythrocyt
acut
respiratori
distress
syndrom
hyperparasitemia
typic
defin
malaria
parasit
infect
greater
circul
red
blood
cell
metabol
complic
common
abnorm
includ
sever
metabol
acidosi
lifethreaten
hypoglycemia
although
fever
almost
univers
symptom
malaria
infect
differ
plasmodium
speci
may
somewhat
variabl
clinic
present
tabl
sever
malaria
often
due
infect
p
falciparum
reach
higher
parasit
level
speci
p
falciparum
account
unit
state
malaria
case
seen
child
travel
contrast
p
vivax
p
oval
infect
rare
fatal
carri
risk
reactiv
dormant
liverstag
parasit
chronic
asymptomat
bloodstream
infect
may
result
p
malaria
infect
also
caus
nephrot
syndrom
immun
complex
deposit
kidney
less
often
seen
travel
p
knowlesi
zoonot
malaria
parasit
longtail
macaqu
increasingli
recogn
caus
sever
human
infect
may
misdiagnos
less
harm
p
malaria
speci
protect
strategi
malaria
infect
strongli
recommend
travel
malariaendem
region
approv
vaccin
malaria
malaria
prevent
requir
awar
risk
malaria
infect
prevent
mosquito
bite
encourag
adher
antimalari
chemoprophylact
regimen
health
care
provid
must
first
help
assess
travel
risk
contract
malaria
determin
endem
particular
local
season
travel
urban
area
aircondit
locat
geograph
region
typic
free
malaria
clinician
provid
pretravel
counsel
consult
current
detail
inform
health
risk
includ
malaria
may
found
center
diseas
control
prevent
cdc
web
site
www
cdcgovmalaria
well
world
health
organ
web
site
http
wwwwho
intmalariatravellersen
parent
guardian
strongli
caution
take
young
children
high
endem
area
part
challeng
provid
suitabl
prevent
chemotherapeut
regimen
approv
use
small
infant
tabl
furthermor
malaria
may
rapidli
fatal
young
pediatr
patient
earli
symptom
p
falciparum
infect
may
go
unrecogn
speci
malaria
mosquitotransmit
therefor
first
line
protect
infect
prevent
bite
anophel
spp
insect
repel
contain
deet
picaridin
recommend
protect
expos
skin
reappli
everi
hour
warmer
climat
protect
cloth
worn
long
sleev
pant
tuck
sock
appropri
footwear
help
tip
treat
cloth
repel
longlast
insecticid
permethrin
readili
avail
onlin
retail
last
sever
cloth
wash
final
travel
strongli
recommend
use
insecticidetr
mosquito
bed
net
mesh
size
smaller
mm
particularli
effect
nightfeed
gambia
vector
addit
barrier
protect
chemoprophylaxi
offer
adult
children
travel
endem
malaria
region
specif
regimen
dictat
travel
risk
acquir
malaria
local
antimalarialresist
pattern
provid
encourag
follow
countryspecif
recommend
cdc
http
wwwcdcgovmalariatravelerscountrytableahtml
unit
state
approv
malaria
chemoprophylaxi
option
includ
atovaquoneproguanil
chloroquin
doxycyclin
mefloquin
primaquin
see
tabl
case
p
falciparum
malaria
infect
result
inadequ
adher
prophylact
regimen
failur
take
precaut
mosquito
selfreport
adher
rate
american
militari
personnel
less
proper
educ
risk
malaria
efficaci
prevent
method
shown
improv
adher
prevent
measur
particularli
import
rise
rate
intern
travel
summari
abc
malaria
prevent
follow
awar
risk
malaria
includ
understand
incub
period
possibl
delay
onset
symptom
symptom
especi
fever
b
bite
effort
reduc
likelihood
mosquito
bite
c
chemoprophylaxi
use
antimalari
drug
target
blood
liverstag
parasit
prevent
progress
infect
diseas
symptom
malaria
highli
variabl
clinician
maintain
high
index
suspicion
return
travel
present
fever
clinician
continu
consid
routin
pediatr
infect
viral
bacteri
respiratori
tract
infect
infecti
diarrhea
urinari
tract
infect
patient
fever
alter
mental
statu
seizur
cerebr
malaria
may
mimic
bacteri
mening
particular
concern
young
children
may
complet
routin
vaccin
travel
return
hajj
part
mening
belt
subsaharan
africa
import
addit
consider
travel
includ
typhoid
fever
especi
children
younger
year
dengu
common
malariaendem
region
clinician
maintain
awar
ongo
global
infecti
diseas
outbreak
ebola
sever
acut
respiratori
syndrom
sar
may
immedi
infect
control
implic
malaria
suspect
thick
thin
blood
film
peripher
blood
examin
thick
blood
film
provid
sensit
detect
malaria
parasit
wherea
thin
blood
film
permit
speciat
quantif
parasitemia
blood
film
repeat
everi
hour
initi
hour
suspect
malaria
infect
regardless
whether
parasit
observ
later
flowbas
rapid
diagnost
test
rdt
recent
becom
avail
provid
initi
screen
malaria
infect
especi
smaller
facil
may
train
microscopist
staff
time
begin
us
food
drug
administr
fda
approv
binaxnow
malaria
rdt
use
commerci
laboratori
hospit
antigen
detect
kit
high
sensit
specif
p
falciparum
p
vivax
infect
reduc
sensit
p
oval
p
malaria
falseposit
falseneg
result
report
rdt
worldwid
suspect
malaria
continu
evalu
blood
smear
regardless
result
rapid
test
nucleic
acid
test
malaria
remain
gold
standard
highest
sensit
specif
howev
test
unavail
north
american
facil
polymeras
chain
reaction
test
diagnost
confirm
speci
identif
provid
freeofcharg
refer
facil
unit
state
singleag
monotherapi
approach
malaria
treatment
major
contributor
drug
resist
recommend
gener
antimalari
decisionmak
base
sever
symptom
parasit
speci
likelihood
drug
resist
fig
uncompl
p
falciparum
unknown
malaria
speci
infect
effect
treat
regimen
act
combin
fastact
artemisinin
deriv
longeract
antimalari
partner
drug
unit
state
artemetherlumefantrin
coartem
singl
oral
avail
act
treatment
uncompl
malaria
commerci
avail
p
vivax
p
oval
p
malaria
p
knowlesi
infect
acquir
chloroquinesuscept
endem
area
may
treat
chloroquin
otherwis
treatment
act
recommend
importantli
radic
cure
elimin
latent
liver
stage
p
vivax
p
oval
infect
must
addit
treat
malaria
children
cours
primaquin
prevent
futur
relaps
note
patient
must
evalu
presenc
glucos
defici
initi
primaquin
precipit
hemolyt
crisi
patient
sever
malaria
requir
intens
support
care
parenter
treatment
intraven
antimalari
treatment
worldwid
intraven
artesun
strongli
recommend
evid
suggest
improv
surviv
compar
quinin
howev
artesun
commerci
avail
unit
state
therefor
intraven
quinidin
glucon
commonli
avail
treatment
sever
malaria
due
arrhythmogen
cardiotox
quinidin
treatment
requir
cardiac
telemetri
qtc
monitor
intraven
artesun
produc
follow
good
manufactur
practic
made
avail
emerg
basi
investig
new
drug
protocol
fda
ind
protocol
treatment
sever
malaria
unit
state
clinician
treat
pediatr
patient
sever
malaria
encourag
consult
cdc
malaria
hotlin
provid
expert
clinic
advic
releas
intraven
artesun
sever
malaria
patient
quinidin
appropri
addit
malaria
treatment
guidelin
dose
specif
found
cdc
web
site
http
wwwcdcgovmalariadiagnosistreatmenttreatmenthtml
monotherapi
malaria
recommend
therefor
case
sever
malaria
requir
second
agent
tetracyclin
doxycyclin
clindamycin
intraven
oral
consensu
efficaci
exchang
blood
transfus
sever
diseas
pediatricspecif
treatment
modif
may
necessari
treatment
malaria
children
pyrimethamin
avoid
first
week
life
compet
bilirubin
may
aggrav
neonat
hyperbilirubinemia
data
limit
safeti
toler
primaquin
young
infant
therefor
contraind
children
younger
month
age
tetracyclin
contraind
children
younger
year
age
parenter
antimalari
treatment
may
requir
treatment
uncompl
malaria
children
promin
gastrointestin
symptom
oral
administr
possibl
best
practic
current
practic
best
practic
guidelin
care
path
object
counsel
travel
malariaendem
region
abc
protect
measur
infect
includ
limit
mosquito
contact
chemoprophylaxi
consid
malaria
differenti
infant
child
present
nonspecif
febril
ill
particularli
return
travel
rapid
recognit
diagnosi
malaria
infect
necessari
prevent
diseas
progress
treatment
malaria
depend
diseas
sever
plasmodium
speci
likelihood
antimalari
resist
chang
current
practic
like
improv
outcom
improv
adher
antimalari
regimen
prevent
techniqu
proper
travel
educ
travel
histori
obtain
pediatr
patient
present
fever
flulik
symptom
monotherapeut
regimen
promot
develop
drug
resist
avoid
diagnosi
depend
microscop
analysi
rapid
antigen
test
thick
thin
blood
smear
combin
malaria
treatment
base
diseas
sever
parasit
speci
likelihood
drug
resist
p
vivax
p
oval
primaquin
treatment
follow
test
necessari
prevent
relaps
latent
liver
stage
properli
inform
travel
malariaendem
region
prevent
measur
infect
effect
mean
promot
adher
prevent
transmiss
event
malaria
infect
high
index
suspicion
rapid
diagnosi
immedi
treatment
critic
prevent
morbid
mortal
associ
diseas
progress
particularli
pediatr
patient
